Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 2
2006 4
2007 7
2008 3
2009 1
2010 6
2011 14
2012 9
2013 19
2014 21
2015 9
2016 11
2017 7
2018 6
2019 8
2020 10
2021 18
2022 14
2023 10
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Kratochwil C, et al. Among authors: ezziddin s. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845. doi: 10.1007/s00259-023-06255-8. Epub 2023 May 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37246997 Free PMC article.
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. Kratochwil C, et al. Among authors: ezziddin s. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544. doi: 10.1007/s00259-019-04485-3. Epub 2019 Aug 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31440799
[Neuroendocrine neoplasms of the breast].
Anlauf M, Neumann M, Bomberg S, Luczak K, Heikaus S, Gustmann C, Antke C, Ezziddin S, Fottner C, Pavel M, Pape UF, Rinke A, Lahner H, Schott M, Cremer B, Hörsch D, Baum RP, Groh U, Alkatout I, Rudlowski C, Scheler P, Zirbes TK, Hoffmann J, Fehm T, Gabbert HE, Baldus SE. Anlauf M, et al. Among authors: ezziddin s. Pathologe. 2015 May;36(3):261-70. doi: 10.1007/s00292-015-0024-0. Pathologe. 2015. PMID: 25986886 Review. German.
[Somatostatin receptor PET/CT (SSTR-PET/CT)].
Boy C, Poeppel T, Kotzerke J, Krause BJ, Amthauer H, Baum RP, Buchmann I, Ezziddin S, Führer D, Gabriel M, Kuwert T, Lahner H, Lauenstein T, Maecke HR, Nagarajah J, Rösch F, Scheidhauer K, Schmidt M, Walter MA, Bockisch A. Boy C, et al. Among authors: ezziddin s. Nuklearmedizin. 2018 Feb;57(1):4-17. doi: 10.1055/s-0038-1636560. Epub 2018 Feb 21. Nuklearmedizin. 2018. PMID: 29536494 German.
[Neuroendocrine neoplasms of the distal jejunum and ileum].
Anlauf M, Sipos B, Boeck I, Baldus SE, Heikaus S, Krausch M, Knoefel WT, Begum N, Goretzki P, Schott M, Auernhammer CJ, Cremer B, Rinke A, Ezziddin S, Fottner C, Pöpperl G, Lahner H, Hörsch D, Gabbert HE, Komminoth P, Perren A, Klöppel G, Wiedenmann B, Pavel M, Pape U. Anlauf M, et al. Among authors: ezziddin s. Pathologe. 2014 May;35(3):283-93; quiz 294. doi: 10.1007/s00292-013-1888-5. Pathologe. 2014. PMID: 24671468 Free article. Review. German.
Advances in Peptide Receptor Radionuclide Therapy.
Sabet A, Biersack HJ, Ezziddin S. Sabet A, et al. Among authors: ezziddin s. Semin Nucl Med. 2016 Jan;46(1):40-6. doi: 10.1053/j.semnuclmed.2015.09.005. Semin Nucl Med. 2016. PMID: 26687856 Review.
Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks.
Pfestroff A, Luster M, Jilg CA, Olbert PJ, Ohlmann CH, Lassmann M, Maecke HR, Ezziddin S, Bodei L; Radionuclide Therapy Committee of the European Association of Nuclear Medicine. Pfestroff A, et al. Among authors: ezziddin s. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1971-5. doi: 10.1007/s00259-015-3186-3. Eur J Nucl Med Mol Imaging. 2015. PMID: 26373947 No abstract available.
Radium-223 in prostate cancer.
Biersack HJ, Ezziddin S, Knapp FF. Biersack HJ, et al. Among authors: ezziddin s. N Engl J Med. 2013 Oct 24;369(17):1659. doi: 10.1056/NEJMc1310231. N Engl J Med. 2013. PMID: 24152266 No abstract available.
Ectopic Cushing Syndrome Localized by 68Ga-DOTA-LM3 PET/CT.
Bastian MB, Rosar F, Burgard C, Blickle A, Ezziddin S. Bastian MB, et al. Among authors: ezziddin s. Clin Nucl Med. 2024 Aug 28. doi: 10.1097/RLU.0000000000005408. Online ahead of print. Clin Nucl Med. 2024. PMID: 39207826
[161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617.
Schaefer-Schuler A, Burgard C, Blickle A, Maus S, Petrescu C, Petto S, Bartholomä M, Stemler T, Ezziddin S, Rosar F. Schaefer-Schuler A, et al. Among authors: ezziddin s. Theranostics. 2024 Feb 24;14(5):1829-1840. doi: 10.7150/thno.92273. eCollection 2024. Theranostics. 2024. PMID: 38505615 Free PMC article.
170 results